Part 2: Practical Considerations For Venetoclax in AML


Expert continues discussion on important considerations for the optimal use if venetoclax in patients with AML, such as CYP3A4 and p-glycoprotein drug interactions.

Related Videos
MP Studio -
Image credit: David A Litman |
Credit: AkuAku -
Image credit: Halfpoint |
Credit: AkuAku -
Image Credit: © Mongta Studio -
Image credit: Halfpoint |
luchschenF -
© 2024 MJH Life Sciences

All rights reserved.